AccessibilityHelpAbout Us
Nano-X Imaging logo

Nano-X Imaging(NASDAQ) NNOX

Market Cap$57.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-97%
5 Year-97%
1 Year-82%
1 Month-21%
$0.75
-4.97%
-0.04Today
After hours$0.77+$0.02 (+3.22%)
Nano-X Imaging last closing stock price
MetricPriceDate
Last closeUSD 0.732026-09-18
Nano-X Imaging stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.42%USD 0.722026-09-11
1 month-21.06%USD 0.932026-08-19
3 month-56.04%USD 1.672026-06-18
Year to date-73.78%USD 2.802025-12-31
1 year-82.35%USD 4.162025-09-18
3 year-89.2%USD 6.802023-09-19
5 year-96.98%USD 24.332021-09-17
Since inception-96.62%USD 21.702020-08-21

Nano-X Imaging Financials at a Glance

Market Cap

$57.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$15.63M

Net Income (TTM)

-$116.81M

EPS (TTM)

-$1.71

P/E Ratio

-0.43

Dividend

$0.00

Beta (Volatility)

1.83 (High)

Price

$0.75

Volume

876,227.621

Open

$0.80

Previous Close

$0.73

Daily Range

$0.73 - $0.81

52-Week Range

$0.67 - $4.71

Estimated Earnings Date

Nov 19, 2026

NNOX News

A semiconductor chip on blue board.

What Companies Does Nvidia Own?

Jeremy BowmanMar 19, 2026
Healthcare professional inspecting charts

Why Nano X Imaging Stock Crushed it Today

Eric VolkmanNov 25, 2025
Healthcare professional inspecting charts

Why Nano-X Imaging Stock Skyrocketed by 26% on Friday

Eric VolkmanNov 21, 2025
Doctor uses a pad to review a 3-D hologram x-ray.

Why Nano-X Imaging Stock Soared Today

Rich SmithApr 17, 2025
Healthcare professional inspecting charts

Why Nanox Stock Slumped Today

Eric VolkmanMar 31, 2025
happy businessperson at their computer

Here's Why Nanox Stock Went Up Today

Jon QuastDec 5, 2024
Healthcare workers examine projections of digital images.

3 Artificial Intelligence (AI) Stocks That Could Go Parabolic

Scott LevineAug 13, 2024
Investor-thinking-about-stock-charts-getty

Down 53%. Is Nano-X Imaging a Buy on the Dip?

Cory RenauerMay 30, 2024
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nano-X Imaging

Nano-X Imaging Ltd. is a pioneering company in the medical imaging sector, focusing on the development of advanced tomographic imaging devices. The company utilizes innovative digital X-ray technology and offers a range of services, including teleradiology and AI applications for healthcare.

Products and Services
  • Nanox.ARC: A prototype medical imaging system with proprietary digital X-ray technology
  • Nanox.CLOUD: A cloud-based platform for medical screening as a service
  • Teleradiology Services: Remote imaging interpretation for various healthcare facilities
Growth Outlook
  • Projected increase in demand for medical imaging solutions globally
  • Expansion of AI-driven software solutions for healthcare entities
  • Strategic partnerships to enhance service offerings and market reach
Financial Highlights
  • Q2 2026 revenue of $4.16 million, showing consistent performance
  • Cash and cash equivalents of $31.02 million as of June 30, 2026
  • Current ratio of 2.84, indicating strong liquidity position
Nano-X Imaging Ltd. is positioned to capitalize on the growing demand for innovative medical imaging solutions. The company's focus on advanced technology and AI applications enhances its competitive edge in the healthcare sector. Recent financial data indicates a stable revenue stream and a solid liquidity position, which may attract potential investors looking for opportunities in the medical devices industry. The strategic direction of Nano-X, combined with its innovative product offerings, suggests a promising future in the evolving landscape of healthcare technology.
AI Generated • Sep 18, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

197

CEO

Erez I. Meltzer, MBA

Website

www.nanox.vision

Headquarters

Petah Tikva, 4970602, IL

NNOX Financials

Key Financial Metrics (TTM)

Gross Margin

-338.20%

Operating Margin

-654.94%

Net Income Margin

-747.20%

Return on Equity

-94.35%

Return on Capital

-41.13%

Return on Assets

-128.10%

Earnings Yield

-2.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$57.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

78.59M

Volume

876.23K

Avg. Volume

2.14M

Financials (TTM)

Gross Profit

-$52.87M

Operating Income

-$102.39M

EBITDA

-$90.94M

Operating Cash Flow

-$47.79M

Capital Expenditure

-$5.49M

Free Cash Flow

-$53.28M

Cash & ST Invst.

$31.02M

Total Debt

$7.73M

Nano-X Imaging Performance Analysis

Nano-X Imaging annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 8,578,000557.8%
20232023-12-31USD 9,905,00015.5%
20242024-12-31USD 11,283,00013.9%
20252025-12-31USD 13,021,00015.4%
Nano-X Imaging sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3013.4%
Q42025-12-317.9%
Q12026-03-3115.9%
Q22026-06-30-3.6%
Nano-X Imaging annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2.1769.2%
20232023-12-31USD -1.08-50.3%
20242024-12-31USD -0.91-15.4%
20252025-12-31USD -1.1626.9%
Nano-X Imaging sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.7%
Q42025-12-31-138.1%
Q12026-03-3160.0%
Q22026-06-30-295.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$4.16M

+36.7%

Gross Profit

-$43.67M

-1248.0%

Gross Margin

-10.51%

N/A

Market Cap

$57.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$292.85K

N/A

Employees

197

N/A

Net Income

-$55.49M

-276.9%

EBITDA

-$52.66M

-356.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$31.02M

-40.3%

Total Debt

$7.73M

-2.9%

Accounts Receivable

$1.89M

+0.4%

Inventory

$3.42M

+51.8%

Long Term Debt

$3.83M

+2.7%

Short Term Debt

$3.90M

-7.7%

Return on Assets

-1.28%

N/A

Return on Invested Capital

-1.32%

N/A

Free Cash Flow

-$12.58M

-21.4%

Operating Cash Flow

-$11.59M

-24.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OMOutset Medical, Inc.
$3.15+1.61%
SNWVSANUWAVE Health Inc.
$4.55+10.17%
MXCTMaxCyte, Inc.
$1.19-0.42%
HCATHealth Catalyst, Inc.
$1.79-0.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$152.71-1.36%
NVDANvidia
$222.27+1.34%
AGNCAGNC Investment Corp.
$9.87-0.40%
INTCIntel
$108.60-0.18%

Questions About NNOX

What is the current price of Nano-X Imaging?

Nano-X Imaging is trading at $0.73 per share.

What is the 52-week range for Nano-X Imaging?

Over the past 52 weeks, Nano-X Imaging has traded between $0.67 and $4.71.

How much debt does Nano-X Imaging have?

As of the most recent reporting period, Nano-X Imaging reported total debt of $7.73M.

How much cash does Nano-X Imaging have on hand?

Nano-X Imaging reported $31.02M in cash and cash equivalents in its most recent financial results.

What is Nano-X Imaging’s dividend yield?

Nano-X Imaging does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services